Possible recurrence of symptoms after discontinuation of omalizumab in anti-IgE-assisted desensitization to egg

Pediatr Allergy Immunol. 2014 Nov;25(7):717-9. doi: 10.1111/pai.12259. Epub 2014 Aug 29.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Allergens / immunology
  • Antibodies, Anti-Idiotypic / administration & dosage*
  • Antibodies, Anti-Idiotypic / adverse effects
  • Antibodies, Monoclonal, Humanized / administration & dosage*
  • Antibodies, Monoclonal, Humanized / adverse effects
  • Child
  • Desensitization, Immunologic / methods*
  • Egg Hypersensitivity / immunology
  • Egg Hypersensitivity / therapy*
  • Female
  • Humans
  • Immunoglobulin E / blood
  • Infant
  • Omalizumab
  • Ovomucin / immunology
  • Ovum / immunology
  • Recurrence
  • Treatment Outcome
  • Withholding Treatment

Substances

  • Allergens
  • Antibodies, Anti-Idiotypic
  • Antibodies, Monoclonal, Humanized
  • Omalizumab
  • Ovomucin
  • Immunoglobulin E